Juan José Lahuerta Palacios
Hospital Universitario 12 de Octubre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Juan José Lahuerta Palacios as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05849610 · Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple MyelomaPETHEMA Foundation · active not recruiting · High-Risk de Novo Multiple Myeloma · study chair
- Ph3NCT05558319 · NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-IberdomidePETHEMA Foundation · recruiting · Newly Diagnosed Multiple Myeloma · study chair
- Ph2NCT05527340 · Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.PETHEMA Foundation · active not recruiting · Multiple Myeloma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.